Sign-up for Ruthigen Announces First Patient Enrollment in the Phase 1/2 Human Clinical Trial of RUT58-60, a Broad-Spectrum Anti-Infective Drug Candidate Designed for Prophylactic Use During Invasive Surgery investment picks
Renaissance Gold Inc. (TSX: REN) (“RenGold” or the “Company”) is pleased
to announce the start of drilling at Wood Hills South by Newmont USA
Limited in the evolving Pequop Gold District, Elko County Nevada.
Office Depot, Inc. (“Office Depot”, or the “company”) (Nasdaq:ODP), a
leading global provider of office
products, services, and solutions formed by the merger of
Office Depot and OfficeMax Incorporated (“OfficeMax”), today announced
results for the third quarter and nine months ended September 27, 2014.
AIRPORT CITY BUSINESS PARK, ISRAEL --
Foundation Medicine, Inc. (NASDAQ: FMI) and COTA, Inc. today announced
an agreement to capture and analyze comprehensive genomic, clinical
outcome, and cost data from patients who have undergone testing with
FoundationOne ® .
- Third quarter 2014 EYLEA® (aflibercept) Injection global net sales increased 48% to $722 million (consisting of $445 million in the U.S. and $277 million in rest of world(1)) versus third quarter 2013
- Third quarter 2014 non-GAAP net income(2) increased 6% to $295 million, or $2.52 per diluted share, which included a $34 million charge ($0.29 per diluted share) for purchase of priority review voucher - Estimated full year 2014 EYLEA U.S. net sales tightened to $1.7 billion - $1.74 billion TARRYTOWN, N.Y. , Nov.
Independent. Insightful. Trusted. Morningstar provides stock market analysis; equity, mutual fund, and ETF research, ratings, and picks; portfolio tools; and option, hedge fund, IRA, 401k, and 529 plan research. Our reliable data and analysis can help both experienced enthusiasts and newcomers.